Bessemer Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16
Closed 2514
2025
Q3
$0 Buy
16
+8
+100% +$302 ﹤0.01% 2469
2025
Q2
$0 Hold
8
﹤0.01% 2380
2025
Q1
$1K Buy
+8
New +$696 ﹤0.01% 2299
2024
Q2
Sell
-135
Closed -$21K 2029
2024
Q1
$21K Sell
135
-71
-34% -$11.8K ﹤0.01% 1416
2023
Q4
$65K Buy
206
+3
+1% +$1.09K ﹤0.01% 1292
2023
Q3
$90K Hold
203
﹤0.01% 1228
2023
Q2
$88K Hold
203
﹤0.01% 1258
2023
Q1
$121K Buy
+203
New +$114K ﹤0.01% 1027

Other funds holding AGL

Bessemer Group's AGL Position: Q4 2025 in Review

Bessemer Group sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 16 shares.

Bessemer Group first reported a position in AGL in Q1 2023 and held it in 8 quarters. The position peaked at $121K in Q1 2023. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Bessemer Group reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Bessemer Group sold 16 Agilon Health shares in Q4 2025.
  • Bessemer Group first reported a position in Agilon Health in Q1 2023 and held it in 8 quarters.
  • Bessemer Group's Agilon Health position peaked at $121K in Q1 2023.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Bessemer Group's 13F filing for Q4 2025, filed 5 Feb 2026.